| Literature DB >> 25117987 |
T L Crume1, J Crandell2, J M Norris1, D Dabelea1, M T Fangman2, D J Pettitt3, L Dolan4, B L Rodriguez5, R O'Connor6, E J Mayer-Davis2.
Abstract
The association between timing of complementary food introduction and age at diagnosis of type 1 diabetes was investigated among 1077 children in the SEARCH for Diabetes in Youth study. Age at diagnosis was 5 months earlier for children introduced to sugar-sweetened beverages (SSB) in the first 12 months of life compared with those who were not (9.0±0.2 vs 9.5±0.1; P=0.02) independent of human leukocyte antigen (HLA) risk status. Analyses stratified by HLA risk status found that children with a high-risk HLA genotype had an earlier age at diagnosis if they were introduced to fruit juice in the first year of life (mean age at diagnosis=9.3±0.1, 9.1±0.1 and 9.6±0.2 for introduction at ⩽6 months, between 7 and 11 months and ⩾12 months, respectively; P=0.04). Introduction of SSB in the first year of life may accelerate the onset of type 1 diabetes independent of HLA risk status.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25117987 PMCID: PMC4414319 DOI: 10.1038/ejcn.2014.159
Source DB: PubMed Journal: Eur J Clin Nutr ISSN: 0954-3007 Impact factor: 4.016
Mean age at diagnosis of type 1 diabetes by timing of introduction of complementary foods into the infant diet on a regular basis (at least once per week).
| Predicted mean age at diagnosis (years) ± SE (N=1,077) | |||||
|---|---|---|---|---|---|
| Age at introduction (months) | <3m | 3-6m | 7-11m | 12m or more | P-value |
|
| 9.41 ± 0.15 | 9.42 ± 0.08 | 9.38 ± 0.14 | 0.95 | |
|
| 9.50 ± 0.08 | 9.31 ± 0.1 | 9.31 ± 0.18 | 0.08 | |
|
| 9.39 ± 0.16 | 9.4 ± 0.08 | 9.32 ± 0.13 | 9.74 ± 0.22 | 0.38 |
|
| 9.43 ± 0.23 | 9.45 ± 0.09 | 9.36 ± 0.09 | 9.49 ± 0.14 | 0.73 |
|
| 9.46 ± 0.08 | 9.34 ± 0.1 | 9.27 ± 0.16 | 0.29 | |
|
| 9.36 ± 0.17 | 9.43 ± 0.08 | 9.43 ± 0.13 | 9.38 ± 0.21 | 0.96 |
|
| 9.42 ± 0.11 | 9.39 ± 0.09 | 9.47 ± 0.11 | 0.74 | |
|
| 9.45 ± 0.09 | 9.41 ± 0.11 | 9.29 ± 0.11 | 9.49 ± 0.12 | 0.42 |
|
| 9.44 ± 0.11 | 9.42 ± 0.09 | 9.42 ± 0.09 | 0.97 | |
|
| 9.43 ± 0.09 | 9.32 ± 0.1 | 9.49 ± 0.11 | 0.29 | |
|
| 9.04 ± 0.18 | 9.45 ± 0.08 | 0.02 | ||
Least-squares predicted means from model adjusted for sex, race, education, income, birth year, breastfeeding (never, 1-5m vs. ≥6m), HLA risk status (low risk/protective vs. high risk/susceptible) and in utero maternal DM exposure.
Note: cell size less than 30 were collapsed with the adjoining cell to improve precision.
Model-estimated mean age at diagnosis of type 1 diabetes for windows of introduction of complementary foods, for youth with moderate and high HLA risk genotypes.
| Low Risk/Protective HLA (estimated mean age at diagnosis ± SE) (N=684) | High Risk/ Susceptible HLA (estimated mean age at diagnosis ± SE) (N=316) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Age at introduction (months) | <3m | 3-6m | 7-11m | ≥ 12m | p-value | <3m | 3-6m | 7-11m | ≥ 12m | p-value | Overall P for interaction[ |
|
| 9.40 ± 0.17 | 9.45 ± 0.08 | 9.40 ± 0.16 | 0.9 | 9.44 ± 0.25 | 9.33 ± 0.11 | 9.32 ± 0.21 | 0.9 | 0.86 | ||
|
| 9.55 ± 0.09 | 9.30 ± 0.11 | 9.30 ± 0.2 | 0.05 | 9.39 ± 0.12 | 9.33 ± 0.15 | 9.35 ± 0.34 | 0.9 | 0.6 | ||
|
| 9.33 ± 0.18 | 9.43 ± 0.08 | 9.37 ± 0.15 | 9.77 ± 0.26 | 0.5 | 9.54 ± 0.28 | 9.31 ± 0.11 | 9.21 ± 0.21 | 9.67 ± 0.38 | 0.6 | 0.8 |
|
| 9.51 ± 0.09 | 9.34 ± 0.11 | 9.26 ± 0.18 | 0.3 | 9.33 ± 0.12 | 9.35 ± 0.15 | 9.36 ± 0.32 | 0.7 | 0.5 | ||
|
| 9.58 ± 0.27 | 9.53 ± 0.1 | 9.34 ± 0.1 | 9.51 ± 0.16 | 0.2 | 9.07 ± 0.43 | 9.29 ± 0.13 | 9.42 ± 0.14 | 9.45 ± 0.24 | 1.0 | 0.3 |
|
| 9.28 ± 0.19 | 9.47 ± 0.09 | 9.5 ± 0.15 | 9.34 ± 0.23 | 0.7 | 9.57 ± 0.3 | 9.34 ± 0.11 | 9.27 ± 0.21 | 9.59 ± 0.45 | 0.8 | 0.5 |
|
| 9.48 ± 0.12 | 9.45 ± 0.09 | 9.40 ± 0.12 | 0.9 | 9.26 ± 0.17 | 9.27 ± 0.12 | 9.66 ± 0.17 | 0.09 | 0.1 | ||
|
| 9.47 ± 0.1 | 9.52 ± 0.12 | 9.3 ± 0.13 | 9.44 ± 0.14 | 0.4 | 9.39 ± 0.15 | 9.12 ± 0.18 | 9.26 ± 0.17 | 9.52 ± 0.18 | 0.3 | 0.3 |
|
| 9.50 ± 0.12 | 9.47 ± 0.1 | 9.41 ± 0.1 | 0.8 | 9.29 ± 0.19 | 9.3 ± 0.13 | 9.41 ± 0.13 | 0.7 | 0.6 | ||
|
| 9.47 ± 0.1 | 9.39 ± 0.11 | 9.39 ± 0.13 | 0.7 | 9.3 ± 0.13 | 9.13 ± 0.16 | 9.63 ± 0.16 | 0.04 | 0.09 | ||
|
| 9.15 ± 0.21 | 9.48 ± 0.08 | 0.1 | 8.74 ± 0.35 | 9.41 ± 0.11 | 0.06 | 0.4 | ||||
Adjusted for sex, race, education, income, birth year, breastfeeding, HLA risk status and in utero maternal DM exposure
Heterogeneity of effect between age at diagnosis and age at introduction by HLA genotype category was tested in the model with an interaction term.
Note: cell size less than 30 were collapsed with the adjoining cell to improve precision.